VT vs XLV
Vanguard Total World Stock ETF vs Health Care Select Sector SPDR Fund
- • VT has the lower expense ratio at 0.06% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.72%).
Side-by-side metrics
| Metric | VT | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.06% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.67% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $89.90B | $37.88B |
YTD return | 10.19% | -5.69% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.98 | 0.58 |
P/E ratio | 23.55 | 26.68 |
Last price | $153.72 | $144.72 |
Inception | — | — |
Issuer | Vanguard | State Street |
VT top holdings
| NVDA | NVIDIA Corp | 3.97% |
| AAPL | Apple Inc | 3.56% |
| MSFT | Microsoft Corp | 2.67% |
| AMZN | Amazon.com Inc | 1.95% |
| GOOGL | Alphabet Inc Class A | 1.63% |
| AVGO | Broadcom Inc | 1.39% |
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 1.37% |
| GOOG | Alphabet Inc Class C | 1.32% |
| META | Meta Platforms Inc Class A | 1.22% |
| TSLA | Tesla Inc | 1.02% |
XLV top holdings
| LLY | Eli Lilly and Co | 14.07% |
| JNJ | Johnson & Johnson | 10.52% |
| ABBV | AbbVie Inc | 7.10% |
| UNH | UnitedHealth Group Inc | 6.38% |
| MRK | Merck & Co Inc | 5.15% |
| AMGN | Amgen Inc | 3.54% |
| TMO | Thermo Fisher Scientific Inc | 3.42% |
| ISRG | Intuitive Surgical Inc | 3.09% |
| GILD | Gilead Sciences Inc | 3.08% |
| ABT | Abbott Laboratories | 3.00% |
About VT
VT (Vanguard Total World Stock ETF) is All-world equities in a single fund. Managed by Vanguard, the fund carries $89.9B in assets under management, an expense ratio of 0.06%, a dividend yield of 1.67%. Its largest holding is NVIDIA Corp (NVDA), which represents 4.0% of the portfolio. Real Estate is the fund's largest sector exposure at 2.5%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $37.9B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.